Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
On average, the scalp contains between 100,000 and 150,000 hairs , with approximately 150 hairs renewed daily
Eur J Clin Pharmacol 81, 15551568
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Supports Normal Mood *
US$ 28.89
US$ 22.73
US$ 22.29
